« back to directory

About NeuroScientific Biopharmaceuticals

NeuroScientific Biopharmaceuticals Ltd is an Australian public company developing novel peptide-based pharmaceutical products that target a number of neurological disorders that have high unmet medical needs.

The Company’s current R&D program is focused on developing a treatment for stroke-related brain injury and dementia / Alzheimer’s disease, and a diagnostic for early-stage Alzheimer’s disease.